Results 221 to 230 of about 115,833 (340)

Implantable cardiac pacemakers. [PDF]

, 1968
E Sowton
openalex   +1 more source

Symptomatic Deep Venous Thrombosis of the Upper Extremity Following Transvenous Lead Extraction, Data From EXTRACT Registry

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Venous thrombosis occurring after TLE procedures is a fairly common but poorly described complication and requires further investigation into its causes. Aim The aim of this study was to identify independent predictors of UEDVT occurrence after TLE procedures.
Michal Joniec, Joanna Stachanczyk, Syliwia Gladysz‐Wanha, Eugeniusz Pilat, Anna Drzewiecka, Jolanta Biernat, Andrzej Weglarzy, Wojciech Wanha, Rafal Gardas, Krzysztof S. Golba   +9 more
wiley   +1 more source

Baseline and changes in prognostic nutritional index associate with heart failure hospitalization and all-cause death in patients with cardiac pacemaker. [PDF]

BMC Cardiovasc Disord
Zhang J, Yao H, Lu Y, Lian L, Zheng R, Chen C.   +5 more
europepmc   +1 more source

A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation. [PDF]

J Int Med Res, 2022
Hu B, Zhao J, Liang X, Ren C, Li N, Liang C.   +5 more
europepmc   +1 more source

Syncope in Patients with Cardiac Pacemakers

, 2020
Eduardo Arrais Rocha, Gisele Schineider Cunha, Aline Bezerra Tavares, Antônio Brazil Viana Júnior, Ana Rosa Pinto Quidute, Francisca Tatiana Moreira Pereira, Marcelo de Paula Martins Monteiro, Maria Eduarda Quidute Arrais Rocha, Camila Rabelo Ferreira Gomes, Carlos Roberto Martins Rodrigues Sobrinho   +9 more
openalex   +1 more source

Navigating the Lead Paradox: Successful Co‐Implantation of Cardiac Contractility Modulation Device and a Micra Leadless Pacemaker

Journal of Cardiovascular Electrophysiology, EarlyView.
This central illustration visually summarizes the first co‐implantation of a Cardiac Contractility Modulation (CCM) system and a Micra leadless pacemaker in a 78‐year‐old male with wild‐type transthyretin cardiac amyloidosis and NYHA Class III heart failure.
Gabriele Pavani, Paolo Garrone, Gianpaolo Varalda, Antonino Previti, Matteo Bianco, Alessandra Chinaglia   +5 more
wiley   +1 more source

Ca²⁺/Calmodulin-Dependent Protein Kinase II (CaMKII) Regulates Basal Cardiac Pacemaker Function: Pros and Cons. [PDF]

Cells
Vinogradova TM, Lakatta EG.
europepmc   +1 more source

Twenty years' use of expanded polytetrafluoroethylene sheet for an artificial cardiac pacemaker. [PDF]

Clin Case Rep, 2021
Yorita K, Takahashi J, Tano K, Ichikawa Y, Hamaguchi N, Yasui W.   +5 more
europepmc   +1 more source

Leadless Versus Transvenous Dual‐Chamber Pacemakers: Real‐World Evidence From AVEIR DR Coverage With Evidence Development Study

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background AVEIR DR, an industry‐first dual‐chamber leadless pacemaker (LP), provides continuous atrioventricular synchrony through implant‐to‐implant (i2i) communication between atrial and ventricular LP devices. It is important to evaluate the early real‐world comparative safety of AVEIR DR LP.
Monica Lo, Anish K. Amin, Marcin Kowalski, Anne Kroman, Dilip Mathew, Valay Parikh, Stanislav Weiner, Jennifer M. Joseph, Leonard Ganz, Mohammed Mortada, AVEIR DR Study Group/Consortium   +10 more
wiley   +1 more source

Case report: Safety of Tumor Treating Fields therapy with an implantable cardiac pacemaker in a patient with glioblastoma. [PDF]

Front Oncol
Biedermann GB, Merrifield K, Lustgarten L.   +2 more
europepmc   +1 more source